P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection

P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection

Bibliographic Details
Main Authors:	Frahm N, Noonan L, DeFawe O, Casimiro D, Simandl J, Spies G, McElrath MJ
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.
by: Cheng Cheng, et al.
Published: (2012-01-01)

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination
by: Cheng Cheng, et al.
Published: (2012-01-01)

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.
by: Cheng Cheng, et al.
Published: (2012-01-01)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
by: Frahm N, et al.
Published: (2009-10-01)

Cryptanalysis of 48-step RIPEMD-160
by: Gaoli Wang, et al.
Published: (2017-06-01)

Beetles (Coleoptera) of Peru: A Survey of the Families. Monotomidae Laporte, 1840
by: Thomas McElrath
Published: (2017-07-01)

The Production of Material Suitable to the Reading Level of Dull-Normal First-Grade Children
by: McElrath, Esta
Published: (1943)

The elliptic integral and some applications
by: McElrath, Howard William
Published: (1932)

An ecological study of instructor views of free use multitasking with digital devices in the classroom
by: Week, Sandra McElrath
Published: (2016)

Observations of neutral V-particle decays with the 48" Magnet Cloud Chambers
by: van Lint, Victor A. J.
Published: (1954)

Beyond neutrality: adding habitat filtering to neutral models
by: Wasana Abeysinghe, et al.
Published: (2020-05-01)

Oxytocin and Oxytocinase in the Obese and Nonobese Parturients during Induction and Augmentation of Labor
by: Annemaria De Tina, et al.
Published: (2019-04-01)

NA62 and NA48/2 results on search for Heavy Neutral Leptons
by: Lamanna Gianluca, et al.
Published: (2018-01-01)

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.
by: Diana V Pastrana, et al.
Published: (2012-01-01)

P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study
by: Barouch DH, et al.
Published: (2009-10-01)

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans.
by: Samuel O Pine, et al.
Published: (2011-04-01)

The clinical course of anesthetic induction in lung transplant recipients
by: Toshiyuki, Mizota
Published: (2015)

CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells
by: Nicholas J. Maurice, et al.
Published: (2019-11-01)

Sociální a geografický původ úředníků pražského policejního ředitelství ve druhé polovině 19. století
by: Milan Šimandl
Published: (2020-04-01)

Soukromí v latinských a českých biblických textech
by: Josef Šimandl
Published: (2019-11-01)

Dnešní stav skloňování substantiv takzvaných typů kámen a břímě
by: Šimandl, Josef
Published: (2008)

Early mobilization in LVAD recipients: An obligatory step towards recovery
by: Ugo Corrà, et al.
Published: (2019-03-01)

Early steps in neural induction
by: Stower, M. J.
Published: (2012)

A Randomized Double-Blind Placebo Controlled Trial of Oral Acyclovir in Renal Allograft Recipients
by: Walter F Schlech, et al.
Published: (1993-01-01)

Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.
by: Steven F L van Lelyveld, et al.
Published: (2015-01-01)

The principle and operation of an induction stepping motor
by: Mestha, Lingappa Keshav
Published: (1986)

Azithromycin vs. Placebo for the Clinical Outcome in Campylobacter concisus Diarrhoea in Adults: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
by: Hans Linde Nielsen, et al.
Published: (2016-01-01)

Induction of immune tolerance and altered cytokine expression in skin transplantation recipients
by: Ming-Min Wang, et al.
Published: (2018-06-01)

Induction, recipient deservingness and personality attractiveness : effects on children’s helping behaviors
by: Leung, Jupian Jupchung
Published: (2010)

The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age
by: JiYoon B. Ahn, KMD, MPH, et al.
Published: (2021-07-01)

Intravenous lidocaine infusions for 48 hours in open colorectal surgery: a prospective, randomized, double-blinded, placebo-controlled trial
by: Matthew Liang Jinn Ho, et al.
Published: (2018-02-01)

Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
by: Michael Vaine, et al.
Published: (2010-11-01)

Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.
by: Andrew W Harmon, et al.
Published: (2018-01-01)

P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be?
by: McElrath J, et al.
Published: (2009-10-01)

Black–White Disparities in Criminal Justice Referrals to Drug Treatment: Addressing Treatment Need or Expanding the Diagnostic Net?
by: Karen McElrath, et al.
Published: (2016-10-01)

Prevalence of High-Intensity Drinking from Adolescence through Young Adulthood: National Data from 2016-2017
by: Megan E Patrick, et al.
Published: (2019-01-01)

Social grant recipient spending on sin taxed items / A.D. Pietersen
by: Pietersen, Ashley Deon
Published: (2015)

Social grant recipient spending on sin taxed items / A.D. Pietersen
by: Pietersen, Ashley Deon
Published: (2015)

Fusion of 40Ca + 40Ca, 40Ca + 48Ca and 48Ca + 48Ca
by: Stefanini A.M., et al.
Published: (2011-10-01)

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine
by: Walsh SR, et al.
Published: (2012-09-01)